Cargando…
Regulating the properties of XQ-2d for targeted delivery of therapeutic agents to pancreatic cancers
Enhanced recognition ability, cell uptake capacity, and biostability are characteristics attributed to aptamer-based targeted anticancer agents, and are possibly associated with increased accumulation at the tumor site, improved therapeutic efficacy and reduced negative side effects. Herein, a phosp...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508320/ https://www.ncbi.nlm.nih.gov/pubmed/37731726 http://dx.doi.org/10.1093/nsr/nwad113 |
_version_ | 1785107512472633344 |
---|---|
author | Yang, Qiuxia Peng, Yongbo Deng, Zhengyu Zhang, Dailiang Long, Cheng-Yu Zhang, Guo-Rong Li, Juan Wang, Xue-Qiang Tan, Weihong |
author_facet | Yang, Qiuxia Peng, Yongbo Deng, Zhengyu Zhang, Dailiang Long, Cheng-Yu Zhang, Guo-Rong Li, Juan Wang, Xue-Qiang Tan, Weihong |
author_sort | Yang, Qiuxia |
collection | PubMed |
description | Enhanced recognition ability, cell uptake capacity, and biostability are characteristics attributed to aptamer-based targeted anticancer agents, and are possibly associated with increased accumulation at the tumor site, improved therapeutic efficacy and reduced negative side effects. Herein, a phosphorothioate backbone modification strategy was applied to regulate the biomedical properties of pancreatic cancer cell–targeting aptamer for efficient in vivo drug delivery. Specifically, the CD71- targeting aptamer XQ-2d was modified into a fully thio-substituted aptamer S-XQ-2d, improving the plasma stability of S-XQ-2d and mitomycin C (MMC)-functionalized S-XQ-2d (MFSX), thus considerably prolonging their half-life in mice. Moreover, the binding and uptake capacities of S-XQ-2d were significantly enhanced. MFSX showed the same level of cytotoxicity as that of MMC against targeted cancer cells, but lower toxicity to non-targeted cells, highlighting its specificity and biosafety. Brief mechanistic studies demonstrated that XQ-2d and S-XQ-2d had different interaction modes and internalization pathways with the targeted cells. |
format | Online Article Text |
id | pubmed-10508320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-105083202023-09-20 Regulating the properties of XQ-2d for targeted delivery of therapeutic agents to pancreatic cancers Yang, Qiuxia Peng, Yongbo Deng, Zhengyu Zhang, Dailiang Long, Cheng-Yu Zhang, Guo-Rong Li, Juan Wang, Xue-Qiang Tan, Weihong Natl Sci Rev Research Article Enhanced recognition ability, cell uptake capacity, and biostability are characteristics attributed to aptamer-based targeted anticancer agents, and are possibly associated with increased accumulation at the tumor site, improved therapeutic efficacy and reduced negative side effects. Herein, a phosphorothioate backbone modification strategy was applied to regulate the biomedical properties of pancreatic cancer cell–targeting aptamer for efficient in vivo drug delivery. Specifically, the CD71- targeting aptamer XQ-2d was modified into a fully thio-substituted aptamer S-XQ-2d, improving the plasma stability of S-XQ-2d and mitomycin C (MMC)-functionalized S-XQ-2d (MFSX), thus considerably prolonging their half-life in mice. Moreover, the binding and uptake capacities of S-XQ-2d were significantly enhanced. MFSX showed the same level of cytotoxicity as that of MMC against targeted cancer cells, but lower toxicity to non-targeted cells, highlighting its specificity and biosafety. Brief mechanistic studies demonstrated that XQ-2d and S-XQ-2d had different interaction modes and internalization pathways with the targeted cells. Oxford University Press 2023-04-25 /pmc/articles/PMC10508320/ /pubmed/37731726 http://dx.doi.org/10.1093/nsr/nwad113 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of China Science Publishing & Media Ltd. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Yang, Qiuxia Peng, Yongbo Deng, Zhengyu Zhang, Dailiang Long, Cheng-Yu Zhang, Guo-Rong Li, Juan Wang, Xue-Qiang Tan, Weihong Regulating the properties of XQ-2d for targeted delivery of therapeutic agents to pancreatic cancers |
title | Regulating the properties of XQ-2d for targeted delivery of therapeutic agents to pancreatic cancers |
title_full | Regulating the properties of XQ-2d for targeted delivery of therapeutic agents to pancreatic cancers |
title_fullStr | Regulating the properties of XQ-2d for targeted delivery of therapeutic agents to pancreatic cancers |
title_full_unstemmed | Regulating the properties of XQ-2d for targeted delivery of therapeutic agents to pancreatic cancers |
title_short | Regulating the properties of XQ-2d for targeted delivery of therapeutic agents to pancreatic cancers |
title_sort | regulating the properties of xq-2d for targeted delivery of therapeutic agents to pancreatic cancers |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508320/ https://www.ncbi.nlm.nih.gov/pubmed/37731726 http://dx.doi.org/10.1093/nsr/nwad113 |
work_keys_str_mv | AT yangqiuxia regulatingthepropertiesofxq2dfortargeteddeliveryoftherapeuticagentstopancreaticcancers AT pengyongbo regulatingthepropertiesofxq2dfortargeteddeliveryoftherapeuticagentstopancreaticcancers AT dengzhengyu regulatingthepropertiesofxq2dfortargeteddeliveryoftherapeuticagentstopancreaticcancers AT zhangdailiang regulatingthepropertiesofxq2dfortargeteddeliveryoftherapeuticagentstopancreaticcancers AT longchengyu regulatingthepropertiesofxq2dfortargeteddeliveryoftherapeuticagentstopancreaticcancers AT zhangguorong regulatingthepropertiesofxq2dfortargeteddeliveryoftherapeuticagentstopancreaticcancers AT lijuan regulatingthepropertiesofxq2dfortargeteddeliveryoftherapeuticagentstopancreaticcancers AT wangxueqiang regulatingthepropertiesofxq2dfortargeteddeliveryoftherapeuticagentstopancreaticcancers AT tanweihong regulatingthepropertiesofxq2dfortargeteddeliveryoftherapeuticagentstopancreaticcancers |